chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Head injury, Hypotension, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Medium, Systemic: Hypotension-Medium, Additional Details: Patient received the vaccine and fainted 3-5 minutes later. Patient was standing when he fainted and upon fainting fell down backwards and hit his head on the floor. Paramedics/911 was called immediately. Patient was unresponsive for about 5-10 seconds. Upon waking up, patient seemed dazed at first, but quickly realized where he was and was responsive to questions. Paramedics took patient's blood pressure - it was low - and patient was taken to emergency room for further assessment/monitoring.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Aching in joints; This is a spontaneous report received from a contactable consumer. This consumer (parent) reported for 16 years old male patient that received second dose of bnt162b2 (BNT162B2, Pfizer COVID 19), via an unspecified route of administration, administered in Arm Left on 12Apr2021 15:30 (Lot Number: EP6955) as single dose for covid-19 immunisation. Medical history included attention deficit hyperactivity disorder (ADHD) from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously took first dose of bnt162b2 (BNT162B2, Pfizer COVID 19, Lot Number: EP6955) on 22Mar2021 at 03:30 AM in Arm Left for covid-19 immunisation. The patient experienced aching in joints, continuing for 18 hours on 12Apr2021 18:00 with outcome of recovered. Therapeutic measures were taken as a result of aching in joints included Tylenol and Advil. No covid prior vaccination. No covid tested post vaccination. Known allergies was none. Facility where the most recent COVID-19 vaccine was administered was workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.   No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Eyelids pruritus, Headache, Paraesthesia, Rash
Clinical narrative: This is a spontaneous report from a contactable consumer (patient herself). A 27-years-old female patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EN6208, Expiry Date: unknown) on 21Mar2021 10:00 and second dose on 10Apr2021 both via unspecified route of administration in the left arm at single dose for COVID-19 immunization. The patient denied any medical history. She had no allergies. The patient's concomitant medication included celecoxib. On an unknown date in 2021, after receiving the vaccine, the patient had tingling in hands and feet, headache and pins and needle sensation all over the body, and rash and swelling in eyelids. No emergency room or physician office was involved. No COVID-19 prior vaccination, since the vaccination the patient hadn't been tested for COVID-19. There were no relevant test. The patient did not received treatment. The outcome of the events was not recovered. No follow-up attempts are needed. No further information is expected
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction
Clinical narrative: Anaphylactic reaction; This is a spontaneous report from a contactable consumer (patient). A 50 -Year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER87306), via an unspecified route of administration, administered in left arm on 25Mar2021 at 21:27 (at the age of 50 years old) as a single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 the patient experienced Anaphylactic reaction. The patient visited emergency room on 25Mar2021 and and was released from the emergency room on 26Mar2021. The patient received treatment for the events. Caller stated from her understanding from her doctor she was not anaphylactic to anything in the shot but she had an anaphylactic reaction. Caller stated she wanted know since the vaccine is federally regulated and mandated and she has health insurance but her (Services name) and deductible is high and her being anaphylactic to the shot and receiving care and now receiving bills does Pfizer offer any help with that. Anaphylactic reaction: Caller stated this ended the next morning because it was overnight when she was released from the hospital. Caller clarified she was brought to the emergency room and was released from the emergency room. Treatment: Caller stated she was provided medication at the site of the (Name) and then put in an ambulance and was given medication then transported to the hospital. Caller stated the COVID vaccine she received was the first dose and last dose. Caller stated the physician office was not open and the hospital she wanted to go to was approximately 30 minutes away and she was transported to the nearest hospital to the facility location. The patient did not undergo any lab tests and procedures. The outcome of the events was recovered on 26Mar2021.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat tightness
Clinical narrative: Anaphylactic reaction; This is a spontaneous report from a contactable consumer (patient). A 50 -Year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER87306), via an unspecified route of administration, administered in left arm on 25Mar2021 at 21:27 (at the age of 50 years old) as a single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 the patient experienced Anaphylactic reaction. The patient visited emergency room on 25Mar2021 and and was released from the emergency room on 26Mar2021. The patient received treatment for the events. Caller stated from her understanding from her doctor she was not anaphylactic to anything in the shot but she had an anaphylactic reaction. Caller stated she wanted know since the vaccine is federally regulated and mandated and she has health insurance but her (Services name) and deductible is high and her being anaphylactic to the shot and receiving care and now receiving bills does Pfizer offer any help with that. Anaphylactic reaction: Caller stated this ended the next morning because it was overnight when she was released from the hospital. Caller clarified she was brought to the emergency room and was released from the emergency room. Treatment: Caller stated she was provided medication at the site of the (Name) and then put in an ambulance and was given medication then transported to the hospital. Caller stated the COVID vaccine she received was the first dose and last dose. Caller stated the physician office was not open and the hospital she wanted to go to was approximately 30 minutes away and she was transported to the nearest hospital to the facility location. The patient did not undergo any lab tests and procedures. The outcome of the events was recovered on 26Mar2021.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Retinal vascular thrombosis
Clinical narrative: Retinal Blood clot in right eye; This is a spontaneous report from a contactable consumer.  A 72-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered on right arm on 18Mar2021 11:30 (Batch/Lot Number: EN6024) at single dose (at the age of 72 years old) for COVID-19 immunisation.  Medical history included known allergies: Penicillin, afib, stroke and covid-19 before vaccination. The patient experienced retinal blood clot in right eye on 20Mar2021.  Therapeutic measures were taken as a result of retinal blood clot in right eye (thrombosis). The outcome of the event was not recovered.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Heavy menstrual bleeding, Myalgia, Paraesthesia
Clinical narrative: Extremely heavy (irregular) period with continual bleeding which has with in the last week stopped; Extreme lasting fatigue; Muscle Soreness; Tingling Skin; This is a spontaneous report from a contactable consumer (patient). A 21 years old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE),  dose 1 via an unspecified route of administration, administered in Arm Right on 25Mar2021 14:00 (Lot Number: EN6207) as SINGLE DOSE (at the age of 21 years old) for covid-19 immunisation.  Medical history included ventricular septal defect (VSD) from an unknown date and unknown if ongoing, heart murmur from an unknown date and unknown if ongoing.    There were no concomitant medications.  The patient did not have any known allergies. The patient did not receive any other vaccine within 4 weeks prior to the vaccine.  Prior to the vaccination, the patient was not diagnosed with COVID-19.  It was also reported that since the vaccination, the patient had not been tested for COVID-19. On unknown date, the patient experienced Extremely heavy (irregular) period with continual bleeding which has with in the last week stopped, Extreme lasting fatigue, Muscle Soreness, Tingling Skin. No treatment was received. Outcome of the events was Recovered/Resolved with Sequel.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: This is a spontaneous report received from a contactable consumer (patient). A 16 years old patient received 2nd dose of BNT162B2 (COMIRNATY) on an unspecific date at single dose for COVID-19 immunization. Medical history and concomitant drug were not reported. 14 hrs after receiving COMIRNATY, patient spiked a fever (over 100.3) which has continued for over 24 hours. Outcome of the event was unknown. No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nausea, Pain in extremity, Vomiting
Clinical narrative: arm pain; fatigue; chills; nausea; vomiting; This is a spontaneous report received from a contactable consumer reported for a  female patient received BNT162B2 (COVID-19 vaccine) on 10Apr2021 at single dose for covid-19 immunization. Medical history and concomitant drug were not reported. Patient experienced arm pain, fatigue, chills, nausea and vomiting on 11Apr2021 with outcome was unknown.  No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain, Pain in extremity, Pyrexia
Clinical narrative: chills; aches; fever.; sore arm; This is a spontaneous report received from a contactable consumer (not patient). A 41-year-old male patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose via an unwon route on an unknown date for Covid-19 immunization. Medical history included gastrooesophageal reflux disease. Concomitant drugs included omeprazole (PRILOSEC). Patient experienced adverse events chills, aches, fever on an unknown date. The clinical course was reported as follows: Patient experienced sore arm shortly after receiving Covid 19 vaccination. He also woke up in the middle of the night approx 12:30AM with significant chills, aches and fever. Fever was 102 and managed with paracetamol (TYLENOL) until all symptoms subsided at 4PM. Outcome of the events was resolving.  No follow up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: I just tested positive for covid 3 weeks after my first dose; I just tested positive for covid 3 weeks after my first dose; This is a spontaneous report from a contactable consumer (patient) via the Pfizer sponsored program. A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Lot number: EN6208), via an unspecified route of administration, on Mar2021 as a single dose for COVID-19 vaccination. The patient medical history was not reported.     The patient's concomitant medications were not reported.  The patient reported that: I got my first shot of your covid-19 vaccine 4 weeks ago. I was scheduled to get the second shot in 3 days. I just tested positive for covid 3 weeks after my first dose and was forced to cancel my second dose. patient underwent lab tests and procedures which included covid-19: positive, on Apr2021.  The clinical outcome of the events was unknown.   Information about the Lot/batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Blood count, Confusional state, Insomnia, Mania, Nephrolithiasis
Clinical narrative: may have kidney stone; dramatically increase in the white blood count, "its off the chart".; dramatically increase in the white blood count, "its off the chart".; he gets manic; confused; cant sleep; This is a spontaneous report from a contactable consumer, the patient. A 43 year old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: unknown), dose 2 via an unspecified route of administration on 29Mar2021 as SINGLE DOSE for covid-19 immunisation. The patient's medical history was not reported.  Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: unknown), dose 1 on an unknown date. The patient's concomitant medications were not reported. The patient had blood labs done that showed a dramatic increase in the white blood count, "its off the chart," he gets manic, confused, can't sleep and may have kidney stone on an unspecified date . The patient underwent lab tests and procedures which included blood count: increase in white blood cells. The outcome of increase in the white blood count "its off the chart," manic, confused, can't sleep and may have kidney stone was unknown.  No follow-up attempts are completed; information about lot/batch number cannot be obtained
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count abnormal, White blood cell count increased
Clinical narrative: may have kidney stone; dramatically increase in the white blood count, "its off the chart".; dramatically increase in the white blood count, "its off the chart".; he gets manic; confused; cant sleep; This is a spontaneous report from a contactable consumer, the patient. A 43 year old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: unknown), dose 2 via an unspecified route of administration on 29Mar2021 as SINGLE DOSE for covid-19 immunisation. The patient's medical history was not reported.  Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: unknown), dose 1 on an unknown date. The patient's concomitant medications were not reported. The patient had blood labs done that showed a dramatic increase in the white blood count, "its off the chart," he gets manic, confused, can't sleep and may have kidney stone on an unspecified date . The patient underwent lab tests and procedures which included blood count: increase in white blood cells. The outcome of increase in the white blood count "its off the chart," manic, confused, can't sleep and may have kidney stone was unknown.  No follow-up attempts are completed; information about lot/batch number cannot be obtained
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular
Clinical narrative: first dose 3 days after ending her period/ next period 5 days after her vaccine.; This is a spontaneous report from a contactable consumer (patient). A female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via unspecified route single dose for COVID-19 immunization on unknown date. Medical history and concomitant medication were not reported. The patient had COVID 19 vaccine 3 days after ending her period. She then started her next period 5 days after her vaccine. The patient stated that she had a very regular cycle, so this was not normal for her. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: tested positive for covid after receiving the first covid vaccine; tested positive for covid after receiving the first covid vaccine; This is a spontaneous report from a Pfizer sponsored program received from a non-contactable consumer (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history included was reported as none. Concomitant medications were not reported. The patient reported that she had tested positive for covid after receiving the first covid vaccine on an unspecified date. The patient underwent lab test which included sars-cov-2 test: positive on an unspecified date. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Illness, Injury, Myalgia, Seizure
Clinical narrative: seizures; soreness; extreme fatigue; injured; illness; This is a spontaneous report from a contactable consumer, the patient. This 56-year-old non-pregnant female patient the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 08Apr2021 13:30 (at the age of 56-year-old) as single dose for COVID-19 immunization. Medical history included seizure (not medicated), asthma, allergies, deprived of nightly decent sleep (from 24/7 low frequency torture by neighbor's ventilation system), and allergies: DILANTIN (phenytoin sodium), "1 other seizure drug" and sulfonamide drugs. The patient was receiving unspecified concomitant medication(s). The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 18Mar2021 13:30 (at the age of 56-year-old) as single dose for COVID-19 immunization. On 11Apr2021 00:30, the patient experienced seizure. On an unspecified date in Apr2021, she also experienced the soreness, extreme fatigue, injured and illness. The clinical course was described as follows: "I suffer from occasional seizures for which I am not medicated and I had one after midnight 2 days after the vaccination. Other symptoms were just soreness and extreme fatigue. I suspect this seizure is due to my lack of oxygen from my laying in bed the next day in this case but wanted to report it in case it matters. I normally suffer seizures very rarely and always in bed at 3 or 4 a.m. at times when I am sick or lacking sleep. This time I had my seizure in the bathroom and I am afraid I have no further information except that I likely only had one since I was missing from the bedroom for less than an hour as near as we can tell. I woke up on the floor injured and unaware of my surroundings. I have never had a seizure while awake before unless it was a second one. I have been deprived of nightly decent sleep by several neighbors for over 3 years now by a low frequency noise from a pot grow ventilation system that has caused me illness and was bad near the time of vaccination." No treatment was received for the adverse events. The clinical outcome of the seizure, soreness, extreme fatigue, injured and illness was resolving.  The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow-up.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Cough, Dehydration
Clinical narrative: pneumonia; kidney infection; severely dehydrated; extreme joint pain; fever; chills; uncontrollable shaking; Severe headache; nausea; vomiting; When Coughing, feel pain in uterus; When Coughing, feel pain in uterus; Very sick; weak; This is a spontaneous report from a contactable consumer, the patient. This 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep7533), via an unspecified route of administration in the left arm on 03Apr2021 10:00 (at the age of 30-year-old) as single dose for COVID-19 immunization. There is no medical history reported. Concomitant medication included celecoxib (CELEXA). The patient did not have any allergies to medications, food, or other products. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: E46955), via an unspecified route of administration in the left arm on 11Mar2021 10:00 (at the age of 30-year-old) as single dose for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. Two hours after the vaccination on 03Apr2021 at 12:00, the patient experienced extreme joint pain, fever, chills, uncontrollable shaking; severe headache, nausea and vomiting. No change after 3 days, she went to Emergency Room ended up with pneumonia, a kidney infection and severely dehydrated. She was hospitalized for one day (in Apr2021). When coughing, she feels pain in her uterus. She was very sick for 11 days after the vaccination and was still weak, and her joints continue to hurt. Therapeutic measures were taken included fluids, antibiotics, blood tests and nausea medications. Since the vaccination, the patient had been tested negative for COVID-19 virus via a nasal swab test on 06Apr2021. The patient had recovered with lasting effects from the extreme joint pain, fever, chills, uncontrollable shaking, severe headache, nausea, vomiting, pneumonia, a kidney infection, severely dehydrated, when coughing, feels pain in uterus, and very sick.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Illness, Kidney infection, Nausea, Pneumonia
Clinical narrative: pneumonia; kidney infection; severely dehydrated; extreme joint pain; fever; chills; uncontrollable shaking; Severe headache; nausea; vomiting; When Coughing, feel pain in uterus; When Coughing, feel pain in uterus; Very sick; weak; This is a spontaneous report from a contactable consumer, the patient. This 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep7533), via an unspecified route of administration in the left arm on 03Apr2021 10:00 (at the age of 30-year-old) as single dose for COVID-19 immunization. There is no medical history reported. Concomitant medication included celecoxib (CELEXA). The patient did not have any allergies to medications, food, or other products. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: E46955), via an unspecified route of administration in the left arm on 11Mar2021 10:00 (at the age of 30-year-old) as single dose for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. Two hours after the vaccination on 03Apr2021 at 12:00, the patient experienced extreme joint pain, fever, chills, uncontrollable shaking; severe headache, nausea and vomiting. No change after 3 days, she went to Emergency Room ended up with pneumonia, a kidney infection and severely dehydrated. She was hospitalized for one day (in Apr2021). When coughing, she feels pain in her uterus. She was very sick for 11 days after the vaccination and was still weak, and her joints continue to hurt. Therapeutic measures were taken included fluids, antibiotics, blood tests and nausea medications. Since the vaccination, the patient had been tested negative for COVID-19 virus via a nasal swab test on 06Apr2021. The patient had recovered with lasting effects from the extreme joint pain, fever, chills, uncontrollable shaking, severe headache, nausea, vomiting, pneumonia, a kidney infection, severely dehydrated, when coughing, feels pain in uterus, and very sick.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test, Tremor, Uterine pain, Vomiting
Clinical narrative: pneumonia; kidney infection; severely dehydrated; extreme joint pain; fever; chills; uncontrollable shaking; Severe headache; nausea; vomiting; When Coughing, feel pain in uterus; When Coughing, feel pain in uterus; Very sick; weak; This is a spontaneous report from a contactable consumer, the patient. This 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep7533), via an unspecified route of administration in the left arm on 03Apr2021 10:00 (at the age of 30-year-old) as single dose for COVID-19 immunization. There is no medical history reported. Concomitant medication included celecoxib (CELEXA). The patient did not have any allergies to medications, food, or other products. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: E46955), via an unspecified route of administration in the left arm on 11Mar2021 10:00 (at the age of 30-year-old) as single dose for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. Two hours after the vaccination on 03Apr2021 at 12:00, the patient experienced extreme joint pain, fever, chills, uncontrollable shaking; severe headache, nausea and vomiting. No change after 3 days, she went to Emergency Room ended up with pneumonia, a kidney infection and severely dehydrated. She was hospitalized for one day (in Apr2021). When coughing, she feels pain in her uterus. She was very sick for 11 days after the vaccination and was still weak, and her joints continue to hurt. Therapeutic measures were taken included fluids, antibiotics, blood tests and nausea medications. Since the vaccination, the patient had been tested negative for COVID-19 virus via a nasal swab test on 06Apr2021. The patient had recovered with lasting effects from the extreme joint pain, fever, chills, uncontrollable shaking, severe headache, nausea, vomiting, pneumonia, a kidney infection, severely dehydrated, when coughing, feels pain in uterus, and very sick.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Gout
Clinical narrative: 3 days after receiving vaccine, got a gout flare-up. Within a day, gout spread and covered both feet. 1 day later, spread to right hand. 1 day later, spread to left thumb.Today, spread into left kn; This is a spontaneous report from a contactable consumer.  A 44-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in left arm on 07Apr2021 03:45 (Batch/Lot Number: EN6206) as single dose for covid-19 immunisation. Medical history included gout since 16. Concomitant medication(s) included ibuprofen; naproxen sodium (ALEVE). The patient experienced 3 days after receiving vaccine, got a gout flare-up on 04Apr2021. 1 day later, spread to right hand. 1 day later, spread to left thumb. Today, spread into left knee.  All instances of gout increasing in intensity and pain daily, despite medication. Taking indomethacin and allopurinol as prescribed, not making a dent nor easing pain. Dr prescribed colchicine last night. Girlfriend picking up today. Patient has had gout since 16. Rarely ever get it in more than one joint at a time. At most, had two-joint flareup., very painful (7?). Post-vaccine, have gout in 13 joints and increasing by the day. Pain level is the same, except in more places. This gout attack is significantly different in intensity, speed and spread. This experience is brutal. Patient was immobile and in excruciating pain. Treatment received as Allopurinol, Indomethacin, Colchicine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, has the patient been not tested for COVID-19. No allergies to medications, food, or other products. Outcome was not recovered for gout and condition aggravated and unknown for other events. The event reported as non serious.   No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Body temperature increased, Lethargy, Oropharyngeal pain
Clinical narrative: sore throat; lethargy; body ache; joint pain; temperature was 97.5'F; This is a spontaneous report from a contactable consumer. A 70-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 31Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation.  The patient medical history and  concomitant medications were not reported. Patient previously received the first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 10Mar2021 for covid-19 immunization.The patient experienced sore throat, lethargy, body ache, joint pain, and temperature was 97.5'f in Apr2021.The patient underwent lab tests and procedures which included body temperature: 97.5 fahrenheit in Apr2021.  Outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: sore throat; lethargy; body ache; joint pain; temperature was 97.5'F; This is a spontaneous report from a contactable consumer. A 70-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 31Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation.  The patient medical history and  concomitant medications were not reported. Patient previously received the first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 10Mar2021 for covid-19 immunization.The patient experienced sore throat, lethargy, body ache, joint pain, and temperature was 97.5'f in Apr2021.The patient underwent lab tests and procedures which included body temperature: 97.5 fahrenheit in Apr2021.  Outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: exposed to COVID-19; This is a spontaneous report from a contactable consumer (Patient's daughter) reported for her mother. A 94-year-old female patient (reporter's mother) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: ER8733 and expiry date: not provided), first dose via an unspecified route of administration, in arm left, on 27Mar2021, 10:30 (age at the time of vaccination 94 years-old), as a single dose for COVID-19 immunisation at college campus. Patient's medical history included heart problems, defibrillator, pacemaker, Arthritis, Fibromyalgia, Neuropathy, early stages of dementia. Concomitant medications were not provided. Patient did not receive other vaccine in four weeks of vaccination. It was reported that patient takes the medications at 9 in the morning and 4 at night. Patient received her first dose of Pfizer COVID-19 vaccine on 27Mar2021 and she supposed to get second dose on 17Apr2021. On 08Apr2021 the patient was exposed to COVID-19 by her son's girlfriend who she lives with their family. The patient is currently isolating. Patient's daughter asked if the patient can get the second dose on 17Apr2021 because she was told it was up to 23 days. Outcome of event was unknown.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral
Clinical narrative: This is a spontaneous report received from a contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 10 Mar 2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 10Mar2021 patient received shot 1. Patient experienced very minor lip tingling on 10 Mar 2021, while waiting 15 min, reported it to the nurse, the nurse had patient wait an extra 15 min. Patient left and was fine. Patient went back for the 2nd dose on the 31st. Patient was asked If she experienced any side effects after the 1st dose , patient told the doctors about the lip tingling. Patient was refused the 2nd dose. Outcome of the event was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea
Clinical narrative: Chills; Diarrhea; This is a spontaneous report from a contactable consumer (patient) from a Pfizer sponsored program  support. A 50-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 08Apr2021 at age of 50 years old at single dose for COVID-19 immunization. Medical history included he ate spinach which caused him to have loose stools on 05Apr2021. Concomitant medications were not reported. On 08Apr and 09Apr, he began to experience diarrhea. He took pepto-bismol, which didn't help him so he had been following the BRAT diet and drinking coconut water. He went to an acupuncturist who prescribed Plum Flower curing pills. He asked how long this was going to continue. He also reported having chills after the vaccine. The 2nd dose would be on 29Apr2021. Patient experienced diarrhea and chills the next day after taking the 1st dose. He would like to know how long the diarrhea extended to last. As per the patient he took an anti-diarrhea curing pill which was a Chinese herbal. He would also like to take the 2nd dose a week after the 29Apr2021, which would be on 06May2021. Outcome of events was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Fatigue, Headache, Hypersensitivity
Clinical narrative: Slight chest tightness and very slight difficulty breathing as if he was experiencing allergies; Slight chest tightness and very slight difficulty breathing as if he was experiencing allergies; Slight chest tightness and very slight difficulty breathing as if he was experiencing allergies; fatigue; muscle soreness; injection site soreness; mild nausea; slight nasal congestion; headache; This is a spontaneous report received from a contactable consumer (patient). This 26-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 12Apr2021 01:15 PM in left arm at single dose (lot number=EN6204) for COVID-19 immunization. Medical history included Attention Deficit Hyperactivity Disorder, Obesity, Temporomandibular Joint Dysfunction, Ocular Migraines. No allergies to medications, food, or other products. Concomitant medications included cannabis sativa. The patient previously received first dose of BNT162B2 (Lot number=ER8730) on 22Mar2021 01:00 PM in left arm for COVID-19 immunization. On 13Apr2021 07:00, the patient experienced fatigue, muscle soreness, injection site soreness, mild nausea, slight nasal congestion, headache. Slight chest tightness and very slight difficulty breathing as if he was experiencing allergies which started 14Apr2021 at around 07:30 am while he was setting up for work and had come and gone. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient did not diagnosed with COVID-19.  Since the vaccination, patient had not been tested for COVID-19. No treatment received for the adverse events. The outcome of events was recovering.  No follow-up attempts needed. No further information expected.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nasal congestion, Nausea, Vaccination site pain
Clinical narrative: Slight chest tightness and very slight difficulty breathing as if he was experiencing allergies; Slight chest tightness and very slight difficulty breathing as if he was experiencing allergies; Slight chest tightness and very slight difficulty breathing as if he was experiencing allergies; fatigue; muscle soreness; injection site soreness; mild nausea; slight nasal congestion; headache; This is a spontaneous report received from a contactable consumer (patient). This 26-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 12Apr2021 01:15 PM in left arm at single dose (lot number=EN6204) for COVID-19 immunization. Medical history included Attention Deficit Hyperactivity Disorder, Obesity, Temporomandibular Joint Dysfunction, Ocular Migraines. No allergies to medications, food, or other products. Concomitant medications included cannabis sativa. The patient previously received first dose of BNT162B2 (Lot number=ER8730) on 22Mar2021 01:00 PM in left arm for COVID-19 immunization. On 13Apr2021 07:00, the patient experienced fatigue, muscle soreness, injection site soreness, mild nausea, slight nasal congestion, headache. Slight chest tightness and very slight difficulty breathing as if he was experiencing allergies which started 14Apr2021 at around 07:30 am while he was setting up for work and had come and gone. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient did not diagnosed with COVID-19.  Since the vaccination, patient had not been tested for COVID-19. No treatment received for the adverse events. The outcome of events was recovering.  No follow-up attempts needed. No further information expected.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: tested positive for covid; tested positive; This is a spontaneous report from a Pfizer-sponsored program, Covax US Support from a contactable consumer (patient's parent). A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The reporter's son got the first dose of the vaccine and tested positive for COVID and wanted contact number to reschedule her son for second dose of the vaccine. The outcome of the events was unknown.  Information about the lot/batch number has been requested.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Diarrhoea, Dysphagia, Fatigue, Feeling of body temperature change
Clinical narrative: Diarrhea; Congestion nasal; sniffles, runny nose aching; sniffles, runny nose aching; Coughing; Left arm sore; Hot and cold; Throat sore; Hard time swallowing and feels like she has to force to swallow; "COVID - like symptoms" /side effects she was having almost feels like she has COVID; Fatigue/exhausted/no energy; This is a spontaneous report from a contactable consumer (patient). This 56-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: ER8731) injected intramuscularly in left arm on 12Apr2021 12:30 at single dose for COVID-19 immunization. Medical history and concomitant medications were none. No prior vaccinations within 4 weeks. The patient just got the first vaccine on 12Apr2021. On 13Apr2021, the patient experienced fatigue/ felt exhausted/ no energy.  On 13Apr2021 01:00, she was having coughing/ hadn't stopped coughing, sore left arm, hot and cold, throat was very sore, congestion nasal, sniffles, runny nose aching.  She was nervous about getting second dose.  She was thinking about calling yesterday, but she did not have the energy.  She was having a hard time swallowing and felt like she was having to force herself to swallow. The diarrhea was just twice, on 13Apr2021 14:00 and 17:00. She was concerned about feeling like her throat was closing.  She just kept drinking water.  She was not swollen though. Patient reported that the symptoms were "COVID - like symptoms", the side effects she was having almost feels like she has COVID. No ER or physician's office required. No relevant tests. The outcome of diarrhea was recovering, outcome of fatigue was unknown, outcome of other events was not recovered.    No follow-up attempts are possible; No further information expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Oropharyngeal pain, Pain in extremity, Rhinalgia, Rhinorrhoea
Clinical narrative: Diarrhea; Congestion nasal; sniffles, runny nose aching; sniffles, runny nose aching; Coughing; Left arm sore; Hot and cold; Throat sore; Hard time swallowing and feels like she has to force to swallow; "COVID - like symptoms" /side effects she was having almost feels like she has COVID; Fatigue/exhausted/no energy; This is a spontaneous report from a contactable consumer (patient). This 56-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: ER8731) injected intramuscularly in left arm on 12Apr2021 12:30 at single dose for COVID-19 immunization. Medical history and concomitant medications were none. No prior vaccinations within 4 weeks. The patient just got the first vaccine on 12Apr2021. On 13Apr2021, the patient experienced fatigue/ felt exhausted/ no energy.  On 13Apr2021 01:00, she was having coughing/ hadn't stopped coughing, sore left arm, hot and cold, throat was very sore, congestion nasal, sniffles, runny nose aching.  She was nervous about getting second dose.  She was thinking about calling yesterday, but she did not have the energy.  She was having a hard time swallowing and felt like she was having to force herself to swallow. The diarrhea was just twice, on 13Apr2021 14:00 and 17:00. She was concerned about feeling like her throat was closing.  She just kept drinking water.  She was not swollen though. Patient reported that the symptoms were "COVID - like symptoms", the side effects she was having almost feels like she has COVID. No ER or physician's office required. No relevant tests. The outcome of diarrhea was recovering, outcome of fatigue was unknown, outcome of other events was not recovered.    No follow-up attempts are possible; No further information expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Suspected COVID-19
Clinical narrative: Diarrhea; Congestion nasal; sniffles, runny nose aching; sniffles, runny nose aching; Coughing; Left arm sore; Hot and cold; Throat sore; Hard time swallowing and feels like she has to force to swallow; "COVID - like symptoms" /side effects she was having almost feels like she has COVID; Fatigue/exhausted/no energy; This is a spontaneous report from a contactable consumer (patient). This 56-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: ER8731) injected intramuscularly in left arm on 12Apr2021 12:30 at single dose for COVID-19 immunization. Medical history and concomitant medications were none. No prior vaccinations within 4 weeks. The patient just got the first vaccine on 12Apr2021. On 13Apr2021, the patient experienced fatigue/ felt exhausted/ no energy.  On 13Apr2021 01:00, she was having coughing/ hadn't stopped coughing, sore left arm, hot and cold, throat was very sore, congestion nasal, sniffles, runny nose aching.  She was nervous about getting second dose.  She was thinking about calling yesterday, but she did not have the energy.  She was having a hard time swallowing and felt like she was having to force herself to swallow. The diarrhea was just twice, on 13Apr2021 14:00 and 17:00. She was concerned about feeling like her throat was closing.  She just kept drinking water.  She was not swollen though. Patient reported that the symptoms were "COVID - like symptoms", the side effects she was having almost feels like she has COVID. No ER or physician's office required. No relevant tests. The outcome of diarrhea was recovering, outcome of fatigue was unknown, outcome of other events was not recovered.    No follow-up attempts are possible; No further information expected.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache
Clinical narrative: This is a spontaneous report received from contactable consumer (patient). An 86-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), at same age, intramuscular, administered in arm right on 12Apr2021 13:00 (Batch/Lot Number: AW0158) as single dose for COVID-19 immunization. Medical history included chromosomal abnormalities, diabetes, obesity, migraines, sinus during spring, allergies, compromised immune status, respiratory illness, endocrine abnormalities, headaches and acidity. Concomitant medication included acetylsalicylic acid (ASPIRIN (E.C.)); amlodipine besilate (NORVASC) taken for acidity; and tamsulosin hydrochloride (FLOMAX RELIEF) taken for acidity and one medication for acid for his stomach every day. He has been these taking for years along with a Vitamin D. He was taking all prior to getting the vaccine. The patient previously received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6207), at 86 years old age, Injected in left arm in the muscle on 23Mar2021 for covid-19 immunisation and experienced joint pain. The patient had been experiencing some pretty good amounts of joint pain on his knees, ankles, and lower back. Patient was getting concerned because his joints were bothering him and are painful in his knees and lower back. He also got a headache. Headache started after second shot. He had allergies and sometimes he got headaches. He had a sinus problem and in the spring he got migraines. This was a different type of headache and was a dull headache. The outcomes of events were not recovered. No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Cough, Dyspnoea, Electrocardiogram, Fatigue
Clinical narrative: cough; fatigue; She's been having a hard time breathing, walking up hill, up stairs, doctor gave her an inhaler; low fever; couple days of body ache/body aches in her legs; did not feel well; This is a spontaneous report from a Pfizer- sponsored program Support from a contactable consumer (patient's husband). A 38-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 24Mar2021 as SINGLE DOSE for covid-19 immunisation. The patient medical history and the concomitant medications were not reported. The patient received first dose of vaccine on 24Mar2021. 1 day after vaccine she had low fever, and did not feel well, day 2 she was fine, day 3, having covid like symptoms, cough, fatigue, couple days of body ache. She's been having a hard time breathing, walking up hill, up stairs, doctor gave her an inhaler, that's continued, and no fever. Tested day 4, day 6, and day 8 with PCR tests, and were all negative. On day 3 she had body aches in her legs for a couple days but no other body aches, and she no longer has anymore. The patient underwent three Covid tests, 3-4 days later, 5-6 days later, and 7-8 days later.  The reporter added that it was thought she had Covid so they did a full screen, and she had positive antibodies. It has been three weeks since symptoms, and the worst few days. The patient experienced fatigue, hard time breathing, coughing on 26Mar2021 and not recovered, and experienced low fever, did not feel well, bodyaches in legs on unknown date in Mar2021 with outcome unknown. She was scheduled today for 2nd dose, want to know if she should get the vaccine today.  One doctor said to wait one week because of her symptoms. The patient had an EKG and full blood work - all were normal.  She also has the antibodies, but he does not know how they measure that.  Bloodwork was done approximately 10 days after the vaccine.  She had 3 Covid tests total. She was given three covid tests, all negative, and did test positive for Covid19 antibodies. It is unclear if she had Covid before or after getting the vaccine, and that the physician thought maybe she had covid before getting vaccinated which is what caused her reaction to the vaccine.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.